Join
Live feed
·
PRReleasevia Quantisnow
Artiva Biotherapeutics Inc. logo

Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines

ByQuantisnow·Wall Street's wire, on your screen.
ARTV· Artiva Biotherapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARTV (Artiva Biotherapeutics Inc.) and more on Quantisnow.